NEOG
Neogen CorporationNASDAQHealthcare$9.41+0.21%ClosedMarket Cap: $2.05B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.97
P/S
2.33
EV/EBITDA
-6.21
DCF Value
$-19.97
FCF Yield
0.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.0%
Operating Margin
-2.0%
Net Margin
-68.5%
ROE
-26.9%
ROA
-63.1%
ROIC
-0.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $224.7M | 47.5% | $-5.4M | $-15.9M | $-0.07 | — |
| Q1 2026 | $209.2M | 34.4% | $-16.0M | $36.3M | $0.17 | — |
| Q4 2025 | $225.5M | 30.8% | $-7.9M | $-612.2M | $-2.82 | — |
| FY 2025 | $894.7M | 47.1% | $9.4M | $-1.09B | $-5.03 | — |
| Q3 2025 | $221.0M | 39.4% | $12.0M | $-11.0M | $-0.05 | — |
| Q2 2025 | $231.3M | 38.8% | $17.1M | $-456.3M | $-2.10 | — |
| Q1 2025 | $217.0M | 39.8% | $8.7M | $-12.6M | $-0.06 | — |
| Q4 2024 | $236.8M | 47.9% | $17.6M | $-5.4M | $-0.03 | — |
| FY 2024 | $924.2M | 50.1% | $77.4M | $-9.4M | $-0.04 | — |
| Q3 2024 | $228.8M | 50.5% | $11.7M | $-2.0M | $-0.01 | — |
| Q2 2024 | $229.6M | 50.9% | $20.9M | $-3.5M | $-0.02 | — |
| Q1 2024 | $229.0M | 51.0% | $19.1M | $1.5M | $0.01 | — |